Review



park2 gene overexpression plasmid  (Shanghai GenePharma)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Shanghai GenePharma park2 gene overexpression plasmid
    Park2 Gene Overexpression Plasmid, supplied by Shanghai GenePharma, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/park2+gene+overexpression+plasmid/human+park2+overexpression+lentivirus/pm29515107-232-7-20
    Average 90 stars, based on 1 article reviews
    park2 gene overexpression plasmid - by Bioz Stars, 2026-10
    90/100 stars

    Images

    Related Articles

    Over Expression:

    Article Title: PARK2 inhibits osteosarcoma cell growth through the JAK2/STAT3/VEGF signaling pathway.
    Article Snippet: Constructing stable overexpression cell lines (transfection) A PARK2 gene overexpression (PARK2) plasmid and negative control (NC) plasmid were purchased from Genepharma corporation (Shanghai, China).

    Article Title: PARK2 inhibits osteosarcoma cell growth through the JAK2/STAT3/VEGF signaling pathway
    Article Snippet: A PARK2 gene overexpression (PARK2) plasmid and negative control (NC) plasmid were purchased from Genepharma corporation (Shanghai, China).

    Transfection:

    Article Title: PARK2 inhibits osteosarcoma cell growth through the JAK2/STAT3/VEGF signaling pathway.
    Article Snippet: Constructing stable overexpression cell lines (transfection) A PARK2 gene overexpression (PARK2) plasmid and negative control (NC) plasmid were purchased from Genepharma corporation (Shanghai, China).

    Article Title: PARK2 inhibits osteosarcoma cell growth through the JAK2/STAT3/VEGF signaling pathway
    Article Snippet: A PARK2 gene overexpression (PARK2) plasmid and negative control (NC) plasmid were purchased from Genepharma corporation (Shanghai, China).

    Plasmid Preparation:

    Article Title: PARK2 inhibits osteosarcoma cell growth through the JAK2/STAT3/VEGF signaling pathway.
    Article Snippet: Constructing stable overexpression cell lines (transfection) A PARK2 gene overexpression (PARK2) plasmid and negative control (NC) plasmid were purchased from Genepharma corporation (Shanghai, China).

    Article Title: PARK2 inhibits osteosarcoma cell growth through the JAK2/STAT3/VEGF signaling pathway
    Article Snippet: A PARK2 gene overexpression (PARK2) plasmid and negative control (NC) plasmid were purchased from Genepharma corporation (Shanghai, China).

    Negative Control:

    Article Title: PARK2 inhibits osteosarcoma cell growth through the JAK2/STAT3/VEGF signaling pathway.
    Article Snippet: Constructing stable overexpression cell lines (transfection) A PARK2 gene overexpression (PARK2) plasmid and negative control (NC) plasmid were purchased from Genepharma corporation (Shanghai, China).

    Article Title: PARK2 inhibits osteosarcoma cell growth through the JAK2/STAT3/VEGF signaling pathway
    Article Snippet: A PARK2 gene overexpression (PARK2) plasmid and negative control (NC) plasmid were purchased from Genepharma corporation (Shanghai, China).

    Immunohistochemistry:

    Article Title: PARK2 inhibits osteosarcoma cell growth through the JAK2/STAT3/VEGF signaling pathway.
    Article Snippet: Constructing stable overexpression cell lines (transfection) A PARK2 gene overexpression (PARK2) plasmid and negative control (NC) plasmid were purchased from Genepharma corporation (Shanghai, China).

    Article Title: PARK2 inhibits osteosarcoma cell growth through the JAK2/STAT3/VEGF signaling pathway
    Article Snippet: A PARK2 gene overexpression (PARK2) plasmid and negative control (NC) plasmid were purchased from Genepharma corporation (Shanghai, China).

    Expressing:

    Article Title: PARK2 inhibits osteosarcoma cell growth through the JAK2/STAT3/VEGF signaling pathway.
    Article Snippet: Constructing stable overexpression cell lines (transfection) A PARK2 gene overexpression (PARK2) plasmid and negative control (NC) plasmid were purchased from Genepharma corporation (Shanghai, China).

    Article Title: PARK2 inhibits osteosarcoma cell growth through the JAK2/STAT3/VEGF signaling pathway
    Article Snippet: A PARK2 gene overexpression (PARK2) plasmid and negative control (NC) plasmid were purchased from Genepharma corporation (Shanghai, China).

    Western Blot:

    Article Title: PARK2 inhibits osteosarcoma cell growth through the JAK2/STAT3/VEGF signaling pathway.
    Article Snippet: Constructing stable overexpression cell lines (transfection) A PARK2 gene overexpression (PARK2) plasmid and negative control (NC) plasmid were purchased from Genepharma corporation (Shanghai, China).

    Article Title: PARK2 inhibits osteosarcoma cell growth through the JAK2/STAT3/VEGF signaling pathway
    Article Snippet: A PARK2 gene overexpression (PARK2) plasmid and negative control (NC) plasmid were purchased from Genepharma corporation (Shanghai, China).

    Immunofluorescence:

    Article Title: PARK2 inhibits osteosarcoma cell growth through the JAK2/STAT3/VEGF signaling pathway.
    Article Snippet: Constructing stable overexpression cell lines (transfection) A PARK2 gene overexpression (PARK2) plasmid and negative control (NC) plasmid were purchased from Genepharma corporation (Shanghai, China).

    Article Title: PARK2 inhibits osteosarcoma cell growth through the JAK2/STAT3/VEGF signaling pathway
    Article Snippet: A PARK2 gene overexpression (PARK2) plasmid and negative control (NC) plasmid were purchased from Genepharma corporation (Shanghai, China).

    Flow Cytometry:

    Article Title: PARK2 inhibits osteosarcoma cell growth through the JAK2/STAT3/VEGF signaling pathway.
    Article Snippet: Constructing stable overexpression cell lines (transfection) A PARK2 gene overexpression (PARK2) plasmid and negative control (NC) plasmid were purchased from Genepharma corporation (Shanghai, China).

    Article Title: PARK2 inhibits osteosarcoma cell growth through the JAK2/STAT3/VEGF signaling pathway
    Article Snippet: A PARK2 gene overexpression (PARK2) plasmid and negative control (NC) plasmid were purchased from Genepharma corporation (Shanghai, China).

    Wound Healing Assay:

    Article Title: PARK2 inhibits osteosarcoma cell growth through the JAK2/STAT3/VEGF signaling pathway.
    Article Snippet: Constructing stable overexpression cell lines (transfection) A PARK2 gene overexpression (PARK2) plasmid and negative control (NC) plasmid were purchased from Genepharma corporation (Shanghai, China).

    Article Title: PARK2 inhibits osteosarcoma cell growth through the JAK2/STAT3/VEGF signaling pathway
    Article Snippet: A PARK2 gene overexpression (PARK2) plasmid and negative control (NC) plasmid were purchased from Genepharma corporation (Shanghai, China).

    Migration:

    Article Title: PARK2 inhibits osteosarcoma cell growth through the JAK2/STAT3/VEGF signaling pathway.
    Article Snippet: Constructing stable overexpression cell lines (transfection) A PARK2 gene overexpression (PARK2) plasmid and negative control (NC) plasmid were purchased from Genepharma corporation (Shanghai, China).

    Article Title: PARK2 inhibits osteosarcoma cell growth through the JAK2/STAT3/VEGF signaling pathway
    Article Snippet: A PARK2 gene overexpression (PARK2) plasmid and negative control (NC) plasmid were purchased from Genepharma corporation (Shanghai, China).

    Transwell Assay:

    Article Title: PARK2 inhibits osteosarcoma cell growth through the JAK2/STAT3/VEGF signaling pathway.
    Article Snippet: Constructing stable overexpression cell lines (transfection) A PARK2 gene overexpression (PARK2) plasmid and negative control (NC) plasmid were purchased from Genepharma corporation (Shanghai, China).

    Article Title: PARK2 inhibits osteosarcoma cell growth through the JAK2/STAT3/VEGF signaling pathway
    Article Snippet: A PARK2 gene overexpression (PARK2) plasmid and negative control (NC) plasmid were purchased from Genepharma corporation (Shanghai, China).

    Staining:

    Article Title: PARK2 inhibits osteosarcoma cell growth through the JAK2/STAT3/VEGF signaling pathway.
    Article Snippet: Constructing stable overexpression cell lines (transfection) A PARK2 gene overexpression (PARK2) plasmid and negative control (NC) plasmid were purchased from Genepharma corporation (Shanghai, China).

    Article Title: PARK2 inhibits osteosarcoma cell growth through the JAK2/STAT3/VEGF signaling pathway
    Article Snippet: A PARK2 gene overexpression (PARK2) plasmid and negative control (NC) plasmid were purchased from Genepharma corporation (Shanghai, China).

    Control:

    Article Title: PARK2 inhibits osteosarcoma cell growth through the JAK2/STAT3/VEGF signaling pathway.
    Article Snippet: Constructing stable overexpression cell lines (transfection) A PARK2 gene overexpression (PARK2) plasmid and negative control (NC) plasmid were purchased from Genepharma corporation (Shanghai, China).

    Article Title: PARK2 inhibits osteosarcoma cell growth through the JAK2/STAT3/VEGF signaling pathway
    Article Snippet: A PARK2 gene overexpression (PARK2) plasmid and negative control (NC) plasmid were purchased from Genepharma corporation (Shanghai, China).

    Co-Culture Assay:

    Article Title: PARK2 inhibits osteosarcoma cell growth through the JAK2/STAT3/VEGF signaling pathway.
    Article Snippet: Constructing stable overexpression cell lines (transfection) A PARK2 gene overexpression (PARK2) plasmid and negative control (NC) plasmid were purchased from Genepharma corporation (Shanghai, China).

    Article Title: PARK2 inhibits osteosarcoma cell growth through the JAK2/STAT3/VEGF signaling pathway
    Article Snippet: A PARK2 gene overexpression (PARK2) plasmid and negative control (NC) plasmid were purchased from Genepharma corporation (Shanghai, China).

    Injection:

    Article Title: PARK2 inhibits osteosarcoma cell growth through the JAK2/STAT3/VEGF signaling pathway.
    Article Snippet: Constructing stable overexpression cell lines (transfection) A PARK2 gene overexpression (PARK2) plasmid and negative control (NC) plasmid were purchased from Genepharma corporation (Shanghai, China).

    Article Title: PARK2 inhibits osteosarcoma cell growth through the JAK2/STAT3/VEGF signaling pathway
    Article Snippet: A PARK2 gene overexpression (PARK2) plasmid and negative control (NC) plasmid were purchased from Genepharma corporation (Shanghai, China).



    Similar Products

    park2 gene overexpression plasmid  (Shanghai GenePharma)
    90
    Shanghai GenePharma park2 gene overexpression plasmid
    Park2 Gene Overexpression Plasmid, supplied by Shanghai GenePharma, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/park2+gene+overexpression+plasmid/human+park2+overexpression+lentivirus/pm29515107-232-7-20
    Average 90 stars, based on 1 article reviews
    park2 gene overexpression plasmid - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier

    Image Search Results